Literature DB >> 21155941

Ketamine-induced vesicopathy: a literature review.

S Middela1, I Pearce.   

Abstract

Ketamine consumption in on the increase as a recreational abuse substance. It is reported to cause lower urinary tract symptoms (LUTS), and published accounts of its deleterious effects are increasing. We reviewed the available literature regarding the urological impact of ketamine abuse and its management. Twenty-two publications were found in total after a search of all databases including Pubmed, Medline and Google Scholar using the words 'ketamine', 'bladder' and 'cystitis' with no limits imposed. There are approximately 110 cases reported in the literature in the form of case series, case reports and letters. The effect of ketamine abuse on the bladder is universally similar; however, there is no uniform method adopted in reporting the symptoms, diagnosis and management. Very little is known regarding the pathogenesis of its effects on the urinary tract. Patients with severe irritative LUTS, a positive history of ketamine abuse and the absence of any other aetiology should be considered to have ketamine-induced vesicopathy. Effort must be made to elicit the history of drug abuse in those with no found cause of LUTS, especially in the young. Presently, ketamine cessation is the only effective treatment modality to prevent deterioration of the renal function and indeed offer the possibility of symptom resolution. Management akin to that formulated for interstitial cystitis patients would appear to offer the greatest opportunity for effective treatment.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21155941     DOI: 10.1111/j.1742-1241.2010.02502.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  25 in total

Review 1.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

2.  Illicit ketamine and its bladder consequences: is it irreversible?

Authors:  Rozh Jalil; Suresh Gupta
Journal:  BMJ Case Rep       Date:  2012-10-30

3.  Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug.

Authors:  Danyon J Anderson; Jessica Zhou; David Cao; Matthew McDonald; Maya Guenther; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-15

Review 4.  Cancer pain management: what's new?

Authors:  Jan Gaertner; Christine Schiessl
Journal:  Curr Pain Headache Rep       Date:  2013-04

5.  Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures.

Authors:  Chi-Fai Ng; Peter K F Chiu; Miu-Ling Li; Chi-Wai Man; Simon S M Hou; Eddie S Y Chan; Peggy S K Chu
Journal:  Int Urol Nephrol       Date:  2013-07-18       Impact factor: 2.370

6.  The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.

Authors:  Jacklyn Yek; Palaniappan Sundaram; Hakan Aydin; Tricia Kuo; Lay Guat Ng
Journal:  Singapore Med J       Date:  2015-12       Impact factor: 1.858

7.  A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.

Authors:  Rachel Y K Cheung; Jacqueline H S Lee; Symphorosa S C Chan; Dawn W T Liu; K W Choy
Journal:  Int Urogynecol J       Date:  2014-06-28       Impact factor: 2.894

Review 8.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

9.  Ketamine enhances autophagy and endoplasmic reticulum stress in rats and SV-HUC-1 cells via activating IRE1-TRAF2-ASK1-JNK pathway.

Authors:  Yanming Yu; Daoxu Wu; Yongwei Li; Hui Qiao; Zhengfei Shan
Journal:  Cell Cycle       Date:  2021-08-24       Impact factor: 5.173

10.  Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity.

Authors:  Xingxing Li; Shuangyan Li; Wenhui Zheng; Jian Pan; Kunyu Huang; Rong Chen; Tonghe Pan; Guorong Liao; Zhongming Chen; Dongsheng Zhou; Wenwen Shen; Wenhua Zhou; Yu Liu
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.